NCT06855420

Brief Summary

The long-term effects of vibrating insoles on improving gait, balance and peripheral sensation in people with diabetic peripheral neuropathy remain unknown. The Pathfeel Clinical Trial will investigate the efficacy of vibratory insoles worn for ten days for enhancing sensory perception, gait quality, balance and physical activity in people with mild to severe diabetic neuropathy. The primary outcome will be changes in gait speed and postural and dynamic balance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable diabetes-mellitus

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

November 25, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 3, 2025

Completed
Last Updated

March 3, 2025

Status Verified

February 1, 2025

Enrollment Period

1.1 years

First QC Date

November 25, 2024

Last Update Submit

February 28, 2025

Conditions

Keywords

smart wearable devicevibrationinsolesgaitperipheral sensationbalance

Outcome Measures

Primary Outcomes (2)

  • Postural Balance

    Centre-of-pressure velocity will be assessed using a force platform.

    Measurements were taken at four time points: at baseline, after 10 days of the first vibratory intervention, after a 10-day washout period, and at the end of the 10-day second vibratory intervention.

  • Gait speed during walking

    Gait speed during level and stair walking will be assessed by 3D Motion Capture system.

    Measurements were taken at four time points: at baseline, after 10 days of the first vibratory intervention, after a 10-day washout period, and at the end of the 10-day second vibratory intervention.

Secondary Outcomes (2)

  • Peripheral Sensation

    Measurements were taken at four time points: at baseline, after 10 days of the first vibratory intervention, after a 10-day washout period, and at the end of the 10-day second vibratory intervention.

  • Peripheral Sensation 2

    Measurements were taken at four time points: at baseline, after 10 days of the first vibratory intervention, after a 10-day washout period, and at the end of the 10-day second vibratory intervention.

Study Arms (2)

Vibration

ACTIVE COMPARATOR

Insoles with vibration

Device: Vibration on

No Vibration

PLACEBO COMPARATOR

Insoles without vibration

Device: Vibration off

Interventions

Sole vibration will be applied by a vibrating insole system for 10 days. Participants will wear the device for at least 4 hours per day.

Vibration

Participants will wear the device with vibration turned off for at least 4 hours per day during 10 days of intervention.

No Vibration

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of diabetes type 1 or 2
  • ≥1 palpable foot pulses
  • Presence of mild to moderate diabetic peripheral neuropathy defined by a vibration perception threshold ≥15 Volts and/or mNDS score ≥3.
  • Aged ≥ 18 years
  • Ability to walk unaided for 30 steps
  • Able to understand the study requirements
  • Ability to check their feet regularly (or have another person check).
  • Able to read the study documents
  • Fit shoe size EU 36-47.5 / UK 3.5-13.

You may not qualify if:

  • Active foot ulcer
  • Lower limb amputation (anything more than amputation of two lesser toes)
  • Presence of Charcot deformity
  • Dementia or other cognitive impairment
  • Significant cardiopulmonary or other systemic disease limiting the patient's ability to walk 30 steps.
  • Person's with bodyweight greater than 130kg (due to insole device limitations)
  • Presence of implantable neurostimulators
  • Presence of a pacemaker.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manchester Metropolitan University

Manchester, M15GD, United Kingdom

Location

Related Publications (1)

  • Orlando G, Brown S, Jude E, Bowling FL, Boulton AJM, Reeves ND. Acute Effects of Vibrating Insoles on Dynamic Balance and Gait Quality in Individuals With Diabetic Peripheral Neuropathy: A Randomized Crossover Study. Diabetes Care. 2024 Jun 1;47(6):1004-1011. doi: 10.2337/dc23-1858.

    PMID: 38536962BACKGROUND

MeSH Terms

Conditions

Diabetes MellitusDiabetic Neuropathies

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesDiabetes Complications

Study Officials

  • Neil D. Reeves, PhD, Professor

    Lancaster University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2024

First Posted

March 3, 2025

Study Start

October 1, 2022

Primary Completion

November 1, 2023

Study Completion

November 30, 2023

Last Updated

March 3, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available.

Locations